Bibliographic Details
| Title: |
Circulating tumor DNA as a prognostic biomarker in adjuvant nivolumab therapy for high-risk muscle-invasive urothelial carcinoma: insights from CheckMate 274 and beyond. |
| Authors: |
Yajima S; Department of Urology, National Cancer Center Hospital East, Chiba, Japan., Masuda H; Department of Urology, National Cancer Center Hospital East, Chiba, Japan. |
| Source: |
Translational andrology and urology [Transl Androl Urol] 2026 Apr 27; Vol. 15 (4), pp. 95. Date of Electronic Publication: 2026 Apr 22. |
| Publication Type: |
Editorial; Comment |
| Journal Info: |
Publisher: AME Pub Country of Publication: China NLM ID: 101581119 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2223-4691 (Print) Linking ISSN: 22234683 NLM ISO Abbreviation: Transl Androl Urol Subsets: PubMed not MEDLINE |
| Database: |
MEDLINE Ultimate |
